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The integrin supergene family ofcell adhesion molecules (ISCAM) 1 includes sev-
eral cell surface heterodimers that are involved in both the attachment of cells to
extracellular matrix (ECM) proteins (1, 2) and in cell-cell interactions (3). The het-
erodimers arecomposed ofnoncovalently linked aand/3 chains with molecularmasses
of-130-210 kD and 95-130 kD, respectively, as determined by SDS-PAGE under
nonreducingconditions. The a chain, in some cases, is post-translationally processed
to yield a disulfide-bonded dimer composed ofa larger fragment and a -25-30 kD
subunit (4). Three distinct families ofhuman integrins have been defined based on
theassociationofacommon /3 chain withdistinct achains (1-3). One family, which
wasoriginally termed the verylate activation (VLA) antigens, wasidentified by mAbs
that selectively reacted with lymphoid antigens induced by prolonged antigen or
mitogen stimulation in vitro (5). Recent studies have shown that this family is com-
posed ofat least six distinct a chains associated with a common 0 chain (/31), and
several ofthese dimers are expressed on resting and activated lymphocytes as well
as certain nonlymphoid cells (6, 7). Previously, cell surface receptors for ECM pro-
teins, such as fibronectin and vitronectin, had been determined to be heterodimers
with biochemical features similar to members ofthe VLA family (8, 9). It is now
clear that several members (VLA-2, VLA-3, and VLA-5) ofthis family are cell sur-
face receptors for ECM proteins (2, 10). In those cases where the ECM protein-
receptor interaction has been characterized, the interaction can be frequently in-
hibited by peptides containing the tripeptide, Arg-Gly-Asp (RGD) (11). The second
ISLAM family includes the leukocyte adhesion proteins (LAP) LFA-1, Mac-1, and
p150,95 (the distinct human a chains have beennamedCDlla,b,c, and the common
02 chain, CD18) (3). In contrast to the other two ISLAM families, one member of
the LAP family, LFA-1, appears to be primarily involved in cell-cell interactions (3)
rather thancell-ECM protein interactions. Members ofthe third family oftheISLAM
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use the 03 chain, and include the vitronectin receptor (9) and the platelet gpIIb/IIIa
complex (12).
The studies in this report are derivedfrom our attempts to produce mAbs specific
for cell surface antigens and receptors expressed by a panel of murine dendritic
epidermal T cell (DETC) lines and hybridomas that bear the TCR-y/b (13-16). We
identified a hamster and a rat mAb that selectively reacted with DETC by FACS
analysis and that immunoprecipitated a heterodimeric structure that strongly resem-
bled members of the integrin family. We demonstrate here that these mAbs recog-
nize distinct epitopes on the same a chain, that DETC lines bear ECM protein
receptors, and that these mAbs inhibit the attachment of DETC to ECM proteins.
Since the antigen identified by these mAbs can be induced on peripheral T cells
after prolonged in vitro stimulation with mitogens, and is expressed by certain T
cell clones, we postulate that this antigen plays a physiologic role in T cell function.
Materials and Methods
Media.
￿
All B cell hybridomas were cultured in DME with glucose 4.5 g/liter (Biofluids,
Rockville, MD)supplemented with 10-20% FCS(Biofluids), 10mM Hepes, nonessential amino
acids(0.1 HIM), L-glutamine (300 Ag/ml), sodium pyruvate (1 mM), penicillin G(100 U/ml),
streptomycin (100 hg/ml), and 2-ME (5 x 10-5 M; Aldrich Chemical Co., Milwaukee, WI).
Supplemented RPMI 1640 (Biofluids) contains 10% FCS, Hepes, L-glutamine, penicillin,
and streptomycin at the above concentrations.
Animals.
￿
Armenian hamsters were purchasedfrom Dr. G. Yerganian ofCytogenResearch
and Development (West Roxbury, MA). All mouse strains and Lewis rat were supplied by
the Division of Research Services, National Institutes of Health (Bethesda, MD).
Reagents and CellLines.
￿
Thecloned DETC linesY93A, Y245, T245,T93B, andT184 have
been previously described (13-15). TheDETC hybridomas, T195BW and T245BW IC6.F11,
are the fusion products of a DETC line and BW5147, and have been previously described
(15, 16). The HAT-sensitive nonsecretory murine myeloma Sp2/0-Ag14 was obtained from
the American Type CultureCollection (ATCC, Rockville, MD). The followingcell lineswere
obtained from ATCC except whereindicated andhave been previously described: T cell lines
CTL-L (17), EL-4, BW5147; T cell clones DB14, AE7, and FLA2 (generously provided by
M.Jenkins, NIH) (18-20), D10.G41(21), CE4 (generously provided by G. Trenn, NIH) (22);
IL-3-dependent cell lines 32DC3, DA-1, andFDCP-1 (generously provided byJ. Ihle, Frederick
Cancer Research Facility, Frederick, MD) (23, 24); sarcoma Meth A(providedby E. Gregg,
NIH) (25); fibroblast lines NIH3T3 and BALB 3T3; Bcell hybridoma LS 102.9; monocyte/
macrophage P388DI ; mastocytomaP815. The hamstermAb H1.2F3 (26), and the ratmAbs
7134 (anti-IL-2R, reference 27) and 2AG2 (anti-Fc receptor, 28), and MAR 18.5 (mouse
anti-rat K 29)have been described. HumanrIL-2wasgenerously provided by theCetusCorp.
(Emeryville, CA). The antisera specific for murine TCR Cyl gene product have been de-
scribed (14).
Immunization Protocol and Production in mAb.
￿
Armenian hamsters were initially immunized
with 2 x 10' Y93A cellsemulsified in CFA. The hamsters were then boosted twicewith 2 x
107 viable Y93A cells every 2-3 wk, with the finalboost 3 d before fusion. All injections were
givenintraperitoneally. Two hamsterspleenswere harvested, andcell suspensions were fused
to the HAT-sensitive nonsecretory murine myeloma SP2/0-Ag14 with 50% PEG as previ-
ously described (26). Approximately 2 x 105 cells/well were plated in 96-well tissue culture
plates (Costar, Cambridge, MA)in 100,u] medium, andtheresultant hybridomas were selected
in HAT-containing mediafor 14 d as previously described. Approximately 17 dafter fusion,
100-ttl aliquots of growing wells were used to stain the immunizing cell line and FACS anal-
ysis wasperformed. H9.2B8 was identified as amAb that was reactive with the immunogen
and nonreactive with CTL-L. Wells of interest were cloned by limiting dilution until stable
antibody-producing lines were established. The clones were screened by FACS analysis. TheMAXFIELD ET AL.
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rat mAb 8.18E12 was produced and identified by the same protocol as outlined above, except
that a male Lewis rat was immunized with Y245 cells and the resulting hybridomas were
screened for reactivity with Y245 cells and the CD3- thymoma, BW5147.
The mAb H9.2B8 was affinity purified from spent cell supernatant on a protein A-Sepharose
column (Pharmacia Fine Chemicals, Piscataway, NJ). Optimal conditions for purification
are binding to protein A-Sepharose at pH 8.6 and elution at pH 4.3. Ascitic fluid containing
the mAb 8.18E12 was collected from pristane-primed nude mice injected with the 8.18E12
hybridoma. The mouse anti-rat K mAb, MAR 18.5 that had been purified by protein
A-Sepharose affinity chromatography ofspent culture supernatant, was coupled to cyanogen
bromide-activated Sepharose (Pharmacia Fine Chemicals) according to the manufacturer's
instructions. The mAb 8.18E12 was affinity purified from mouse ascitic fluid with this MAR
18.5-Sepharose column by binding at pH 8.6 and elution at pH 4.3.
Immunoprecipitation Analysis.
￿
The Y245, Y93A, and T245 cell lines, which grow adherent
to plastic, were harvested from tissue culture flasks with PBS containing EDTA 0.02% (Ver-
sene, Gibco Laboratories, Grand Island, NY), washed with PBS, then surface labeled with
Na'211 by the lactoperoxidase method as described previously (14, 15). The cells were washed
with PBS, lysed with 0.5% NP-40 at 108 cells/ml for 30 min at 0°C, and centrifuged at 13,000
g for 15 min. After preclearance overnight at 4°C with 100 pl normal rabbit serum, 100 11
protein A-Agarose (PAA; Bethesda Research Laboratories, Gaithersburg, MD) and 100 JAI
protein G-Agarose (PGA; Genex, Gaithersburg, MD), the lysates were subjected to specific
immunoprecipitations by incubation of 100 til of lysate with 10 pl of purified mAb (10 '~g)
for 60 min followed by an additional 60-min incubation with 10 Al of PAA or PGA (for mAb
8.18E12) beads. The immunoprecipitates were washed three times with 0.5 ml oflysisbuffer,
eluted from the beads, and analyzed on SDS-PAGE (12% acrylamide) gels in the presence
or absence of5 % 2-ME. For the sequential immunoprecipitation experiments, the precleared
lysates were cleared ofmaterial reactive with a particular mAb by five serial incubations with
mAb and agarose beads, followed by pelleting of beads, and reincubation of supernatants
with mAb and agarose beads. For the "off-diagonal" gels, immunoprecipitates were run under
nonreducing conditions for 12 h in an SDS-PAGE (127o acrylamide) cylindrical gel at 0.4
mA/gel. The gel was equilibrated in 2-ME, then layered on a SDS-PAGE slab gel and run
for 12 h at 7 mA/gel. Immunoprecipitation ofthe individual chains was achieved by incuba-
tion of the precleared lysate with a mAb and PAA or PGA beads as above, elution of the
immunoprecipitates under nonreducing conditions (0.05 M Tris, 1% SDS at 80°C for 10
min), or elution from beadsunder reducing and alkylating conditions (0.05 M Tris, 1 % SDS,
0.002 M DTT for 5 min at 67'C followed by an additional 15-min incubation at room tem-
perature with 0.02 M iodoacetamide). The supernatants were then mixed with 400 tl of2.5
NP-40, 0.01 M Tris, and reprecipitated with the appropriate mAb as described above then
analyzed on SDS-PAGE under nonreducing or reducing conditions as appropriate. The gels
were dried, and labeled proteins were visualized by exposure to Kodak XAR5 radiographic
film at -70°C.
Preparation ofActivated Cell Itpulations.
￿
Spleen cell suspensionswere prepared from C3H/HeN
mice and were passed through a sterile nylon wool column as previously described (26). The
nonadherent cells, enriched for T cells, were cultured in supplemented RPMI medium at
106 cell/ml with Con A (5 Ag/ml, Pharmacia Fine Chemicals) in 24-well plates (Costar) for
4 d. Beginning on day 4, the cells were fed supplemented RPMI containing human rIL-2
(20 U/ml) with medium changes every 3-4 d.
FACSAnalysis.
￿
Adherent DETC cell linesand hybridomas were detached from tissue cul-
ture flasks with EDTA 0.02% in PBS (Versene 1 :5,000; Gibco Laboratories, Grand Island,
NY), and washed in FAGS buffer (ice-cold HBSS without phenol red, containing 3% FCS
and 0.1% sodium azide). C3H/HeN thymocyte, mesenteric lymph node, spleen, and bone
marrow cell suspensions were prepared as previously described (26) and washed in FAGS
buffer. Concentrations of antibody that had been previously determined to be saturating were
added to 0.5 x 106 to 1 x 106 cells. After a 30-min incubation on ice, the cells were washed
and appropriate directly FITC-labeled second antibodies were added. In the case ofthe ham-
ster antibodies, FITC-F(ab')2 goat anti-hamster Ig (Cappel Laboratories, Malvern, PA) and
for the rat mAb, FITC-MAR 18.5 were used. After another 30-min incubation on ice and2176
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final washes, 10,000 cells were analyzed on a FACSCAN flow cytometer (Becton Dickinson
& Co., Sunnyvale, CA). Dead cells were excluded from analysis by propidium iodide staining,
and debris were excluded by light scatter parameters.
For the binding inhibition assays, cells were prepared for FAGS analysis as described above,
washed in FAGS buffer, and incubated with saturating concentrations of unlabeled mAb for
15 min on ice. The appropriate concentration of the directly fluoresceinated mAb was then
added for an additional 30 min on ice. After three washes, the cells were analyzed as de-
scribed above.
AdhesionAssay.
￿
Stock preparations ofrat fibronectin (Calbiochem-Behring Corp., LaJolla,
CA), human fibronectin (Calbiochem), rat collagen I (Sigma Chemical, St. Louis, MO),
rat fibrinogen (Sigma), and human vitronectin (Calbiochem), ovalbumin (Sigma), mouse
laminin (Collaborative Research, Bedford, MA), collagen IV (Sigma) were diluted in 0.05
M Tris-buffered saline, pH 9.8. The protein solutions were distributed in 96-well tissue cul-
ture flat-bottomed (Costar) plates at 50 p/well. After an overnight incubation at 37 °C, the
coated wells were washed three times with PBS to remove nonimmobilized protein. To satu-
rate the remaining protein binding sites, 100 141 of adhesion media (serum-free RPMI 1640
with BSA 2 .5 mg/ml; Sigma) was added and the plates were incubated at 37°C for 2 h.
Subconfluent Y93A or T195/BW cultures were labeled with 5 WCi/ml [3H]TdR overnight
at 37°C. The supernatant was discarded and adherent cells were detached by exposure to
0.02% EDTA in PBS for 5 min. The cells were washed three times in adhesion media. If
preincubation was required for the assay, 4 x 10° cells in 100 J1 adhesion media were dis-
tributed to U-bottomed 96-well plates (Costar) containing affinity-purified mAb H9.2B8,
8.18E12, RGDS (Calbiochem), RGES (Peninsula Laboratories Inc., Belmont, CA), or con-
trol hamster mAb (FILM), or control rat mAb (anti-IL-2R, 7134) at 4°C for 20-30 min.
Both control mAbs bind to antigens expressed by the DETC linesused for adhesion assays.
The labeled cellswere then transferred to 96-well plates previously coated with ECM or con-
trol proteins. The plates were centrifuged at 500 rpm for 10-20 s to lightly settle the cells
to the bottom surface and were incubated at 37°C for 3-4 h. Nonadherent cells were removed
from the wells by addition and removal of 100 11 adhesion media three times, and finally,
50 pl ofadhesion media was added to each well. The adherent cellswere harvested onto glass
fiberstrips with the PhD cell harvester (Cambridge Technology, Watertown, MA) and radio-
activity was assessed by liquid scintillation counting. All samples were performed in tripli-
cate. Percent adherence is defined as the remaining cpm divided by the total input cpm (de-
rived from wells that were not washed). There is a linear correlation between the number
of cells in the wells and the cpm measured.
Results
Production of mAbs H9.2B8 and 8.18E12.
￿
To generate mAbs specific for cell sur-
face antigens and receptors expressed by DETC lines, we immunized rats and ham-
sters with DETC lines and fused the immune spleen cells with SP2/0-Ag14. The
resultant antibody producing hybridomas were screened by FRCS analysis for posi-
tive reactivity with the immunogen, and negative reactivity with another T cell line.
The rat mAb 8.18E12 was derived by immunization with the DETC cell line, Y245;
it reacted with the immunogen, but not with the BW5147 cell line. Similarly, the
hamster mAb H9.2B8 was derived by immunization with another DETC cell line,
Y93A, and it reacted with the immunogen, but not with the IL-2-dependent CTL-
L cell line. Both 8.18E12 and H9 .2B8 were cloned by limiting dilution several times
in order to produce stable antibody producing hybridomas. Both mAb were purified
by affinity chromatography for use in the studies reported here.
BiochemicalAnalysis oftheAntigen Recognized by mAbs H9.2B8 and 8.18E12.
￿
The mAbs
H9.2B8 and 8.18E12 immunoprecipitated, from lysates of 1251 surface-labeled Y93A
cells, a similar complex that consisted of 140- and 95-kD bands under nonreducingMAXFIELD ET AL .
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FIGURE 1 .
￿
Immunoprecipitation analysis with mAbsH9.2B8 and
8.18E12 . Lysates of 1251 cell surface labeled Y93A cells were im-
munoprecipitated with normal rabbit serum (lane 1), mAbH9.2B8
(lanes 2 and 4), or mAb 8.18E12 (lanes 3 and 5) and analyzed on
SDS-PAGE under nonreducing conditions (lanes 1-3) or reducing
conditions (lanes 4 and 5) . The Mr is indicated on the right
(x 10-
s) .
conditions that dissociated into 120-, 100-, and23-kDbands in thepresence of2-ME
(Fig . 1) . This result suggested that two of the three chains seen in the reducing gel
are disulfide linked . Furthermore, the 95-kD band appeared to migrate asa 100-kD
band undgr reducing conditions, a result that suggested the presence of intrachain
disulfide bonds . Similar results were obtained with the Y245 and T245 cell lines
(data not shown) .
To clarify the relationship between the subunits reactive with the mAbs, theH9.2B8
immunoprecipitate waselectrophoresed in acylindrical gel undernonreducing con-
ditions, equilibrated with 2-ME, and run under reducing conditions on an SDS-
PAGE slab gel(Fig. 2) . On such "offdiagonal gels," disulfide-linked dimers run below
the diagonal in the same vertical plane, whereas subunits with intrachain disulfide
bondsmay run above the diagonal . The 140-kD species, seen under nonreducing
conditions, thus appeared to be composed of 120-and 23-kD subunits that aredisulfide
linked since they ran in the same vertical plane . The 95-kD protein migrated on
or slightly above thediagonal, separate from the 120/23-kD subunits . Identical results
were obtained with themAb 8.18E12 (data not shown) . These results suggest that
FIGURE2 .
￿
"Off-diagonal" gel analysis
of the antigen recognized by H9.2B8.
Lysates of 1251 labeledY93A cells were
immunoprecipitated with H9.2B8 and
subjected to SDS-PAGE separation in
cylindrical gel under nonreducing con-
ditions (horizontal), then equilibrated
with 2-ME and run under reducing
conditions in the second dimension
(vertical) on an SDS-PAGE slab gel .2178
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the95-kD proteinnoncovalently interactswith the 120/23-kD subunits and contains
intrachain disulfide bonds.
mAb H9.2B8 and 8.18E12 Both Recognize the Same 120 kDa Chain Fragment But Bind
to Distinct Epitopes . Since both mAb H9.2B8 and 8.18E12 immunoprecipitated a
similar antigen complex, the relationship between the determinants reactive with
each mAb was examined in more detail . The identity of the complex precipitated
by each mAb was confirmed by sequential immunoprecipitations . Fig . 3 demon-
stratesthat five steps of sequential preclearingof cell lysateswith mAbH9.2B8 elim-
inated reactivity on subsequent immunoprecipitation with mAb 119 .2138 (Fig . 3,
lane 2) . This precleared lysate no longer contained material reactive with mAb8.18E12
(Fig . 3, lane 3), but control immunoprecipitates with anti-C-y1 antisera were un-
changed (Fig . 3, lane 8) from immunoprecipitates before preclearance (Fig . 3, lane
7) . Identical results were obtained when the initial lysates were precleared with the
mAb 8.18E12 (Fig . 3, lanes 4-6, 9, and 10) . Thus, these data demonstrate that the
mAbs H9.2B8 and 8.18E12 are specifically reactive with the same antigen complex,
a 140- and 95-kD heterodimer that resembles the a and (3 chains, respectively, of
the integrin family.
To determine which subunit is reactive with each mAb, immunoprecipitations
were first performed with eithermAb alone . Theimmunoprecipitates were then ana-
lyzed on SDS-PAGEundernonreducingconditions (H9.2B8, Fig. 4, lane 2 ; 8.18E12,
lane 3) or the precipitates were dissolved in SDS and immunoprecipitated again
with the same mAb (119.2138, Fig . 4, lane 4 ; 8.18E12, lane 5) before SDS-PAGE
analysis undernonreducingconditions . It is clear that both mAbs selectively reacted
with the 140-kD a chain since the second immunoprecipitates contained only the
140-kD chain to theexclusion of the otherchains . Furthermore, if the 119.2138 precipi-
tate was dissolved in SDS and reprecipitated with mAb 8.18E12 (Fig . 4, lane 6) or
FIGURE 3 .
￿
Sequential immunoprecipitations withmAbsH9.B8
and 8.18E12 . Lysates of 1211 cell surface labeledT245 cells were
immunoprecipitated with mAb H9.2B8 (lane 1) or serially
precleared five times with mAb H9.2B8 (lanes 2-3) then im-
munoprecipitated withmAb H9.2B8 (lane 2) ormAb8.18E12
(lane 3) . Similarly, lysates were immunoprecipitated withmAb
8.18E12 (lane 4) or serially precleared five times with mAb
8.18E12 (lanes 5-6) then immunoprecipitated withmAb8.18E12
(lane 5) ormAb H9.2B8 (lane 6) . Control immunoprecipitates
were performed with the anti-T cell receptor antisera specific
for C-yl gene product (lanes 7-10) before (lanes 7 and 9) and
after (lanes 8 and 10) preclearance with mAb H9.2B8 (lanes
7, 8) or 8.18E12 (lanes 9, 10)andanalyzed on an "off-diagonal"
gel . For lanes 7-10, only the relevant portion ofthe gel is shown .MAXFIELD ET AL .
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FIGURE 4 .
￿
mAb H9.2B8 and8.18E12
recognize the same 120-kD a chain
fragment . Lysates of 1251-labeled
Y93A cells were subjected to immuno-
precipitation as follows, with conditions
of SDS-PAGE given in parenthesis
(nonreducing [NR] vs reducing, [R]) .
(Lane 1) Normal rabbit serum ; (lane
2) immunoprecipitate with mAb
H9.2B8 (NR); (lane 3) immunoprecip-
itate withmAb8.18E12 (NR) ; (lane 4)
immunoprecipitate withmAbH9.2B8,
precipitate dissolved inSDSand reim-
munoprecipitated withmAbH9.2B8,
(NR); (lane 5) immunoprecipitate with
mAb8.18E12, precipitate dissolved in
SDS and reprecipitated with mAb
8.18E12 (NR) ; (lane 6) immunoprecip-
itate withmAbH9.2B8, immunopre
cipitate dissolved inSDSandreimmunoprecipitated withmAb 8.18E12, (NR) ; (lane 7) immunoprecipi-
tate withmAb8.18E12, precipitate dissolved inSDS and reimmunoprecipitated withmAbH9.2B8 (NR) ;
(lane 8) same as lane 4 except immunoprecipitate dissolved, reduced, alkylated, then reimmunoprecipi-
tated with mAb H9.2B8 (R); (lane 9) same as lane 5 except immunoprecipitate dissolved, reduced,
alkylated, then reimmunoprecipitated withmAb8.18E12 (R) ; (lane 10) same as lane 2 except R; (lane
11) same as lane 3 except R.
vice versa (Fig . 4, lane 7), the 140-kD chain was precipitated . These data demon-
strate that each mAb is reactive with the same a chain . To determine which of the
a chain fragments is reactive with themAbs, immunoprecipitates were run onSDS-
PAGE under reducing conditions (H9.2B8, Fig . 4, lane 10; 8.18E12, lane 11) or the
precipitates were dissolved in SDS, reduced, alkylated to prevent reassociation of
disulfide bonded subunits, then immunoprecipitated again with the same mAb and
analyzed under reducing conditions (H9.2B8, Fig . 4, lane 8; 8.18E12, lane 9) . This
analysis demonstrated that each mAb specifically reacts with the 120-kD subunit
of the 140-kD a chain.
Although theabove data demonstratethat bothmAbs reactwith theidenticallarger
a chain fragment, binding inhibition studies, performed by FAGS (Fig. 5), demon-
FIGURE 5.
￿
FAGS binding inhibition
assay with mAbHUM or 8.18E12 .
Fl1C-HS.2ss
￿
FITC-8 .1W12
￿
(Left) Y93A cells were preincubated
withFMFbuffer alone (dotted line), un-
labeled mAb H9.2B8 (dashed line), or
unlabeledmAb8.18E12 (solid line) then
stained with FITC-H9.2B8 . (Right)
Y93A cells were preincubated with
FAGS buffer alone (dotted line), unla-
beled mAb 8.18E12 (dashed line), or
mAb H9.2B8 (solid line) then stained
with FITC-8.18E12 . Cells were then
WeFay i
￿
analyzed by FRCS as described . Stain-
ing with irrelevant antibody was iden-
tical to dashed line and is not shown .2180
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strated that the binding ofdirectly fluoresceinated mAb H9.2B8 to Y93A cells was
blockedby preincubationwithunlabeled H9.2B8, but not byunlabeled mAb 8.18E12,
even though unlabeledmAb 8.18E12 completely blocked the bindingofdirectly fluores-
cinated 8.18E12. Moreover, unlabeled H9.2B8 did not inhibitthebinding ofFITC-
8.18E12 . Taken together, these data demonstrate that the mAbs bind to distinct epi-
topes on the larger fragment of the same a chain.
Tissue and CellLine Distribution andInduction ofthe Expression ofthe Antigen Complex
Recognized by mAbs H9.2B8 and 8.18E12. By FAGS analysis, the antigen complex
recognized bymAb H9.2B8 isnot expressed by resting cells in spleen, lymph node,
orthymus cell suspensions, but a significant number (30-40%) ofbonemarrow cells
display the antigen complex (Fig. 6). The staining with mAb 8.18E12 was consis-
tently less bright than that seen with mAb H9.2B8, but there was always a concor-
dance in reactivity with either mAb. ByFACS analysis, themAbs H9.2B8 and 8.18E12
were reactive withall DETC linesand hybridomas tested (Table I). Several Tclones
and tumor lines were also reactive, but the IL-2-dependent CTL-L line was not,
even though a CTL clone, OE4, was positive. The antigen was also present on two
fibroblast lines, NIH3T3 and BALB3T3, but was absent on thefibrosarcoma, Meth
A. In most cases, theintensity ofmAb H9.2B8 stainingwas greaterthanmAb8.18E12,
and in the remaining instances, the low level reactivity with mAb H9.2B8 was cor-
related with a lack of detectable staining with mAb 8.18E12.
Since certain ofthe integrins identified on human T cells (VLA-1 and VLA-2)
are expressed only after 2-3 wk after activation by Con A and maintenance in IL-2
(5), the reactivity of splenic T blasts with mAb H9.2B8 was determined by serial
FACS analysis after Con A stimulation. Whereas the activation antigens Ly-6 and
IL-2R were clearly detectable within 1-2 d after stimulation (27, 30, and data not
shown), definite expression ofthecomplex recognized by H9.2B8 wasnot detectable
on day4 anddidnot occuruntil at leastday7 after stimulation(Fig. 7). This expres-
sion then persisted until the final day of analysis (day 28). Identical results were
obtained with mAb 8.18E12 (data not shown). Since the kinetics ofexpression and
the activation protocol are similar to that described for expression ofthe VLA an-
tigens VLA-1 and VLA-2 (5), these data establish that the antigen recognized by
H9.2B8 and 8.18E12 are expressed in a similar manner i.e., as late activation an-
Log F
￿
InMrgity
FIGURE 6.
￿
FACS analysis oftissue distribu-
tion of antigen complex recognized by mAb
H9.2B8 or 8.18E12. C3H/HEN spleen, lymph
node, thymus, or bone marrow suspensions
were stained with FITC-H9.2B8 (solid line) or
FITC-8.18E12 (dotted line) then subjected to
FACS analysis. Control staining with irrele-
vant mAb is indicated by the dashed line. In
the spleen, lymph node, and thymus panels,
the dotted line is obscured by the solid line.MAXFIELD ET AL .
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TABLE I
FACS Reactivity of mAbs H9.2B8 and 8.18E12
Cell lines were stained with FITC-H9.2B8 or FITC-8.18E12 in the presence
ofmAb 2AG2 and analyzed with a FACScan flow cytometer. In all cases, all
cells were uniformly reactive (or nonreactive) with the mAbs . The relative staining
intensity of the cell lines on a log scale is denoted : + + + , strongly positive ;
+ + , moderately positive ; + , low level positive ; + /- , borderline positive ; - ,
no different than irrelevant control antibody staining .
tigens . Furthermore, expression of this antigen occurred 14 d after alloantigen acti-
vation (data not shown), demonstrating that this late expression can occur after an-
other stimulus .
DETC Lines ExpressECM Protein Receptors.
￿
Both themolecularproperties and the
FACS expression data strongly suggestedthat theantigen identified by thetwomAbs
might represent the murine homologue of one of the human receptors forECM
proteins. In addition, both of the DETC lines that served as immunogens, as well
as allotherDETC lines andhybridomas derived in ourlaboratory, grow as monolayers
that arefirmly adherent to plastic tissue culture vessels, butthat canreadilybe detached
by Ca2+ chelators (Stingl, G., andW . Yokoyama, unpublished observations) . To
Cells
DETC lines and hybridomas :
1-19.2138 8.18E12
T245 + + +
T93B + + +
T184 + + +
T195/13W + + +
T245/BW + +/-
T cell clones :
131314 - -
AE7 + +
FLA2 + +
D IO.G41 - -
OE4 + + +
T cell lines/tumors :
EL4 + +/-
BW5147 + -
CTL-L - -
Others :
32DC3
DA-1
FDCP-1
MethA -
NIH 3T3 +
BALB 3T3 +
SP2/0 -
LS +
P388DI
P8152182
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demonstrate that the antigen identified by the mAbs was involved in the binding
to specific ECM proteins, we devised an assay to quantitate the adhesion of cells
to ECM proteins. Proliferating DETC lines or hybridomas were labeled overnight
with [3H]TdR, detached from culture flasks, washed to remove unincorporated iso-
tope, and then incubated in microtiter plates that had been precoated with irrele-
vant or ECM proteins. After a 3-4-h incubation period, the wells were washed to
remove nonadherent DETC. Theremainingadherent cellswere harvested onto glass
fiber filters, and the amount of [3H]TdR remaining on the filters quantitated by
scintillation counting.
The Y93A cell line specifically bound to human fibronectin, rat fibrinogen, and
at lower levels to human vitronectin, but not to the control protein ovalbumin (Fig.
8). Adhesion was proportional to the protein concentration in the coating buffer,
and at fibrinogen, fibronectin, and vitronectin concentrations above -6.25 ug/ml,
the binding appeared to be maximal, possibly due to saturation of protein binding
Log Fluorescence Intensity
Day is
FIGURE 7.
￿
Mitogen inductionof expression
of antigens recognized by mAb H9.2B8.
Splenic T cells were stimulated with Con A
5 wg/ml then analyzed with FITC-H9.2B8
(solid lines) on the indicated days after stimu-
lation with day 0 beingthe initial dayofcul-
ture. On day4, thecells were washed andcul-
turedin HL-2 (20U/ml). Background staining
with an irrelevant mAb is indicated by the
dashed line.
FIGURE 8.
￿
Adhesion ofY93Acells to ECM-protein.
3H-labeled Y93A cellswere incubated in wellspre-
viously coatedwith increasing concentrations of the
ECM proteins as indicated. Thewells were washed
and the cells remaining were harvested onto glass
filter diskswith aPHDcell harvester. Thediskswere
countedby liquid scintillation counter andpercent
adherencewasdetermined as described in Materials
andMethods. (N)Fibrinogen, (A)fibronectin, (")
vitronectin, (0)collagen I, (O)collagen IV, (A) oval-
bumin, (0) laminin.W
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siteson the plastic surface. The binding of the DETC cell linesto fibrinogen always
appeared to be greaterthan or equalto the bindingto human fibronectin. Thebinding
to human vitronectin was not observed in all studies and always appeared to be less
than thebindingto fibronectin. Comparable results were obtained with rat fibronectin
(Figs. 10 and 11, data not shown). There was no demonstrable specific binding to
collagen I and IV or laminin (Fig. 8), even at coating concentrations of 100 Fog/ml
(data not shown). Similar results were obtained with the DETC line Y245, and the
hybridoma T195/BW (data not shown).
Since the interaction between fibronectin and its cellular receptor canbe specifically
blocked by peptides that contain thetripeptide sequence RGD, and since thebinding
of other ECM proteins to their receptors can be frequently inhibited by the same
tripeptide (11), we performed the bindingstudies in the presence of increasing con-
centrations of the tetrapeptide RGDS or in the presence of a control tetrapeptide
(RGES) that does not affect adhesion to fibronectin (11). The tetrapeptide RGDS
inhibited in adose-dependent manner the bindingofY93A cellsto wells coated with
a constant amount of rat fibronectin, while no inhibition was seen in the presence
of the control peptide (Fig. 9). Similar results were obtained with Y245 cell line
and the T195/BW hybridoma (Fig. 11 and data not shown).
The Binding ofDEMHybridoma andLines to Fibronectin, Fibrinogen, and Vitronectin
isBlockedby the mAbsH9.2B8and8.1SE12. NeithermAb HUM nor 8.18E12 alone
hadany significant effect on T195/BW adhesion to rat fibronectin despite mAb con-
centrations of up to 50 NAg/ml (Fig. 10). However, since the mAbs bind to distinct
8.18E12
H9.2B8 + 8.18E12
FIGURE 9.
￿
Blockade of adhesion to fibronectin
by RGD-containing peptide. Y93A cells were as-
sayed for adhesion to wells coated with constant
amountsofrat fibronectin (10jig/ml)as described
in Fig. 9afterpreincubation with andin thecon-
tinuous presence of increasing concentrations of
the tetrapeptides RGDS or RGES as indicated.
FIGURE 10 .
￿
Blockade ofadhesion to fibronec-
tinwith mAbHUNand8.18E12. Y93A cells
were assayed for adhesion to ratfibronectin-
coated wellsas describedin Fig. 9, afterprein-
cubation with andin thecontinuous presence
of increasing concentrations of the mAbs
H9.2B8 and/or 8.18E12, as indicated.2184
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FIGURE 11 .
￿
Blockade ofadhesion to other ECM proteins
by RGD and mAb H9.2B8 and 8.18E12 . The adhesion of
Y93A cells (top) or T195/BW cells (bottom) to wells coated
with the substrates (10 pg/ml in coating buffer) indicated
were assayed as described in Fig. 9 . The cells were incubated
with RGDS or RGES (10 jig/ml) as described in Fig. 9or
with mAb H9.2B8 and/or 8.18E12 (10 pg/ml) as described
in Fig . 10 . In addition, control incubations with rat mAb
7D4 (10 pg/ml) and/or hamstermAbH1.2F3 (10 pg/ml) are
included in the top panel.
epitopes on the same 120-kD a chain fragment (Figs . 3 and 4), they were examined
together for their effect on adhesion . In combination, mAbs H9.2B8 and 8.18E12
inhibited the adhesion of T195/13W to rat fibronectin at mAb concentrations of 10
jug/ml each . In addition to fibronectin, the adhesion ofY93A cells to rat fibrinogen
(Fig. 11, top)andthe adhesion oftheT195BW hybridomato ratfibrinogen and human
vitronectin (Fig . 11, bottom) were inhibited byRGDS, as expected, and by the combi-
nation of the mAbs H9.2B8 and 8.18E12 . Incubation of the cells with RGES or ei-
ther H9.2B8 or 8.18E12 alone or with control rat and hamster mAbs (Fig . 11, top)
did not inhibit adhesion . Comparable findings were obtained for the DETC line
Y245 (data not shown) . Taken together, these data demonstrate that the binding
oftheDETC lines and hybridoma to all threeECM proteins (fibronectin, fibrinogen,
andvitronectin) canbe inhibited by the combination ofmAbs H9.2B8 and 8.18E12 .
Discussion
The results of our biochemical and functional studies strongly suggest that the
mAbs H9.2B8 and 8.18E12 identify a murine integrin involved in the binding of
cells to ECM proteins . mAbs H9.2B8 and 8.18E12 immunoprecipitate a complex
that consists ofa 140-kD chain that is composed of a 120- and a 23-kD subunit that
aredisulfidelinked. The 140-kD chain is noncovalentlyassociated with a 95-kDchain .
This pattern ofcell surface proteins is characteristic of thea andthe /3 chain, respec-
tively, of certain ISCAM members (1-3, 11) .
We have described a simple, quantitative assayfor cell adhesion toECMproteins .
While previous reports used similar methods for immobilization ofECM proteins
to plastic surfaces, many of the studies use manual cell counting methods to quanti-
tate the assay . Themethod we describe here used microtiter plates, is semi-automated,MAXFIELD ET AL.
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quantitative, and is amenable to large experiments. We have used this assay to de-
termine that murine DETC lines anda DETC hybridomaadhere to the ECM pro-
teins, fibronectin, fibrinogen, and at lower levels, to vitronectin. The lower level of
binding to human vitronectin maybe dueto aloweraffinity for vitronectin binding
to plastic or to a species difference, although the cells appear to adhere equally well
to rat and human fibronectin. Since DETC cell adherence to these ECM proteins
can be blocked by atetrapeptide containing the RGD sequence, these data arecom-
patiblewith previously reported experiments that suggest that many ofthe integrin-
ligand interactions areinhibitable by this peptide sequence (11). Nucleotide sequence
analysis ofhumanintegrins has demonstrated the presence of cx chain domains char-
acteristic ofcation bindingproteins (11, 31). Previous studieshave demonstrated that
Ca" binds to the IIb (a) subunit of the platelet gpIIb/IIIa receptor (32) and that
cations affect the interaction of these receptors with their ligands (33) . These data
are consistent with our observation that the DETC lines, which are extremely ad-
herent to plastic tissue culture flasks, maybe readily detached with cation chelators
like EDTA. While it is possible that the culture media, i.e, FCS, contains ECM pro-
teins like vitronectin (previously named serum spreadingfactor), these observations
are also compatible with the possibility that our DETC cell lines produce an ECM
protein to which the DETC cells attach via their integrins. In this regard, it has
been demonstrated that certain murine Tcell clones can producefibronectin in vitro
(34). The precise character of the ECM protein produced by the DETC cell lines,
if any, is under investigation.
We have established that the mAbs H9.2B8 and 8.18E12 recognize an integrin
because these mAbs, in combination, inhibit the attachment of cells to the ECM
proteins. Whileit is fortuitious that such acombination ofmAbs wasproduced inas-
much as we did not screen for such a functional effect, the mAbs are of different
speciesorigin andwere made against different cell lines. By sequential immunopre-
cipitation experiments, it is clearthat thesemAbs recognize the same antigenic complex
and bind to the same larger a chain fragment. However, the mAbs bind to distinct
epitopes since neither inhibits the binding of the other by FAGS analysis. The re-
quirement for both mAbs to block adherence suggests that both bind separate epi-
topes near the receptor-ligand binding site and that blockade occurs by steric hin-
derance. An alternative view would be that the two distinct antigenic epitopes bind
to two separate sites on the fibronectin molecule and that both fibronectin sites are
necessaryfor complete cell attachment, a concept supported by the recent observa-
tion documentingthat cellscan attach to two different sites on thefibronectin mole-
cule (35, 36). The ability of the mAbs to block the adhesion of the DETC cell lines
to fibronectin, fibrinogen, and vitronectin suggests that a single receptor complex
is responsible for theinteraction oftheDETC with these substrates. However, addi-
tional RGD-dependent integrins that also mediatebindingto these substrates cannot
be excluded, as the mAb blockade does not appear to be as complete as the RGD
blockade.
The precisemolecularrelationship ofthe integrin recognized by the mAbs HUM
and 8.18E12 to the proposed classification system of human integrins (1) cannot be
determined with certainty because ofthe speciesdifference andbecause similar studies
have not been reported for all of the described integrins. Furthermore, no lympho-
cyte integrin hasbeen described that bindsto fibronectin, fibrinogen, and vitronectin.2186
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However, there are distinctive features that have been reported for the human inte-
grins that tend to suggest that the DETC integrin is a member of the 01 or /33 family.
It appears that the DETC integrin is not any of the described members of the LAP
(R2) family, an antigen and' receptor system well characterized on murine cells (3),
because none of the described a chains in the murine or human /32 family have been
noted to dissociate into two fragments, and none have a similar tissue distribution
or ligand specificity. While the DETC integrin bears some resemblance to certain
members of the Qi family, specifically VLA-1 and VLA-2, in that we demonstrated
that the DETC integrin is similarly a late activation antigen (5), the DETC integrin
two fragment a chain resembles instead the structure of the VLA-3 and VLA-5 hu-
man integrins (2). The ligand binding experiments seem to exclude homology to
humanVLA-5 since this receptor apparently bindsonly fibronectin (2). While the hu-
man VLA-3 complex bindsto fibronectin, it also binds to collagen and laminin but
has not been described to bind to fibrinogen or vitronectin (2). Therefore, none of
the VLAantigens have been reported to have all threeproperties, i.e., ligand specificity,
antigenexpression, and twofragment achain, in common with the DETC integrin.
An alternative view is to consider the possibility that theDETC integrin is a member
of the /33 family; both human members, platelet gp Ilb/IIIa and the vitronectin
receptor, have the two-fragment a chain structure (2, 9, 12, 31, 37). Although the
vitronectin receptor reportedly binds only to vitronectin (9), the platelet gp IIb/IIIa
complex has been shown to bind multiple ligands, includingfibronectin, fibrinogen,
vitronectin, andVonWillebrand factor, but not collagen (12, 38); this adhesion pat-
tern is similarto thepatternthat we have established fortheDETC integrins. Neverthe-
less, while humanf1 family members are expressed by both platelets and lympho-
cytes (38-40), the lymphocyte expression of platelet gpIIb/IIIa has not been
convincingly documented. Thus, although further detailed biochemical andmolec-
ular analysis will be required to fully resolve the relationship ofthe murine integrin
described here and human integrins, this is the first'demonstration ofa lymphocyte
receptor that binds to fibronectin, fibrinogen, and vitronectin.
Although all DETC lines examined express theintegrin recognized by mAbs H9.2B8
and 8.18E12 (Table I; Kehn, P, and W. M. Yokoyama, data not shown), we have
been unable to demonstrate staining with these mAbs in situ on fresh epidermal
sheets (Elbe, A., and G. Stingl, data not shown). Since this integrin is expressed
by splenic T cell blasts after mitogen or allostimulation and by several T cell clones,
its expression appears to reflect a state of T cell activation, similar to that initially
described for the VLA antigens, rather than specificity for DETC. In this regard,
the relatively late and prolonged expression of these integrins after T cell stimula-
tion is reminiscent of that reported forthe Pgp-1 antigen. Pgp-1 antigen expression
in vivo has been correlated with prior activation, i.e., as a marker of memory cells
(41). The possible relationship between the expression of the integrin recognized
by mAb HUM and 8.18E12 and T memory cells is presently under investigation.
The role of integrins that bind ECM proteins in T cell ontogeny and function
has not been thoroughly explored. It is likely that these receptors are involved in
lymphocyte trafficking during Tcell ontogeny, since in thedeveloping avianthymus,
precursor hemopoietic cells and thymocytes display fibronectin receptors that are
required forthecells to traverse abasement membrane barrier (42) . Murine thymo-
cyte subset analysis (43) has shown that the fibronectin receptor-bearing cells be-MAXFIELD ET AL .
￿
218 7
long predominantly to the cells that bear the phenotype CD4- , CD8- (double nega-
tive) and large CD4+ , CD8+ rather than small CD4+ , CD8+ or single positives
(CD4+ or CD8+). Since the double-negative subset can give rise to all of the thymo-
cyte subpopulations (44), these data suggest that fibronectin binding plays a role
during the early phases of thymocyte development . Moreover, other studies suggest
that such integrinsmaybe involved in trafficking during the immune response inas-
much asECM proteins are actively synthesized by inflammatory cells (45) andmac-
rophages (46) . Furthermore, VLA+ T cells are found in the synovial fluid ofchron-
ically inflamed rheumatoid arthritisjoints (47) and other sites ofinflammation (48) .
Further dissection of the biochemical and molecular features of the murine inte-
grins should aid the analysis ofthephysiological role of integrins inT cell ontogeny
and in the in vivo immune response, studies that are particularly well suited to mu-
rine studies .
Summary
Cell-cell andcell-extracellular(ECM) protein interactions are mediated through
heterodimers termed integrins. We have demonstrated that dendritic epidermalT
cell (DETC) lines adhere to theECM proteins, fibronectin, fibrinogen, andvitronectin
but not to collagen, laminin, or control proteins . This adhesion was blocked by the
tetrapeptide RGDS~ but notthecontrol peptide, RGES . We have derived ahamster
mAbH9.2B8, and arat mAb, 8.18E12, from immunizations with DETC lines . The
mAbs in combination, but not individually, specifically inhibited the adhesion of
DETC lines to fibronectin, fibrinogen, and vitronectin . Immunoprecipitation anal-
ysis revealed that both mAbs reactedwith aheterodimer composed ofnoncovalently
linked 140- and 95-kD subunits . The 140-kD subunit can be reduced to 120- and
23-kD fragments . Although thetwo mAbs did notcross-compete forbinding to DETC,
sequential immunoprecipitation studies indicatedthat they reactwith thesame 120-
kD fragment . While allDETC cell lines and severalT cell clones were reactive with
the mAbs, the mAbs were not reactive with normal spleen, lymph node, thymus,
or skin. Stimulation of splenic T cells with ConA or allogeneic cells inducedmAb
reactivity after 1 wk in vitro. Thesedata demonstratethat a single lymphocyte receptor,
with biochemical features characteristic ofintegrins, mediatesRGD-dependentbinding
to theECM proteins, fibronectin, fibrinogen, and vitronectin . Furthermore, since
this integrin is expressed by long-term activated T cells, this receptor may play a
physiological role in T cell function,
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